ArticleEndocrine, metabolic & immune disorders drug targets2025

Berberine Improves Glucose and Lipid Metabolism in Obese Mice Through the Reduction of IRE1/GSK-3β Axis-Mediated Inflammation.

Lina Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.